- Home
- GANX vs CEV Comparison
GANX vs CEV Comparison
Compare GANX & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- CEV
- Stock Information
- Founded
- GANX 2017
- CEV 1999
- Country
- GANX United States
- CEV United States
- Employees
- GANX N/A
- CEV N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- CEV Finance/Investors Services
- Sector
- GANX Health Care
- CEV Finance
- Exchange
- GANX Nasdaq
- CEV Nasdaq
- Market Cap
- GANX 57.9M
- CEV 67.8M
- IPO Year
- GANX 2021
- CEV N/A
- Fundamental
- Price
- GANX $1.93
- CEV $9.58
- Analyst Decision
- GANX Strong Buy
- CEV
- Analyst Count
- GANX 5
- CEV 0
- Target Price
- GANX $8.20
- CEV N/A
- AVG Volume (30 Days)
- GANX 226.2K
- CEV 19.6K
- Earning Date
- GANX 05-14-2025
- CEV 01-01-0001
- Dividend Yield
- GANX N/A
- CEV 4.23%
- EPS Growth
- GANX N/A
- CEV N/A
- EPS
- GANX N/A
- CEV 0.36
- Revenue
- GANX N/A
- CEV N/A
- Revenue This Year
- GANX N/A
- CEV N/A
- Revenue Next Year
- GANX N/A
- CEV N/A
- P/E Ratio
- GANX N/A
- CEV $29.36
- Revenue Growth
- GANX N/A
- CEV N/A
- 52 Week Low
- GANX $0.89
- CEV $8.83
- 52 Week High
- GANX $3.19
- CEV $10.91
- Technical
- Relative Strength Index (RSI)
- GANX 53.25
- CEV 39.41
- Support Level
- GANX $1.80
- CEV $9.56
- Resistance Level
- GANX $1.85
- CEV $9.65
- Average True Range (ATR)
- GANX 0.13
- CEV 0.08
- MACD
- GANX -0.00
- CEV -0.01
- Stochastic Oscillator
- GANX 60.00
- CEV 20.59
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.